Nano-liquid chromatography (nLC)-nanoelectrospray (NSI) is one of the cornerstones of mass-spectrometry-based bioanalytics. Nevertheless, the application of nLC is not yet prevalent in lipid analyses. In this study, we established a reproducible nLC separation for global lipidomics and describe the merits of using such a miniaturized system for lipid analyses. In order to enable comprehensive lipid analyses that is not restricted to specific lipid classes, we particularly optimized sample preparation conditions and reversed-phase separation parameters. We further benchmarked the developed nLC system to a commonly used high flow HPLC/ESI MS system in terms of lipidome coverage and sensitivity. The comparison revealed an intensity gain between 2 and 3 orders of magnitude for individual lipid classes and an increase in the linear dynamic range of up to 2 orders of magnitude. Furthermore, the analysis of the yeast lipidome using nLC/NSI resulted in more than a 3-fold gain in lipid identifications. All in all, we identified 447 lipids from the core phospholipid lipid classes (PA, PE, PC, PS, PG, and PI) in Saccharomyces cerevisiae.
A recent publication from Vasilopoulou et al. 1 reports on full lipidome profiling by a combination of trapped ion mobility spectrometry (TIMS), parallel accumulation serial fragmentation (PASEF) and nano HPLC 1 . While this represents an impressive technological advance with the potential to increase lipidome coverage and lower detection limits for individual lipids, the interpretation of the acquired spectra is a matter of concern. Specifically, the authors relied exclusively on software-assisted lipid assignments that were not confirmed by an independent inspection of matched spectra to recognize abundant structurally unique lipid fragments. Further, no attempts were made to correlate the retention times of identified species with available lipid standards, which constitutes the gold standard typically employed in lipidomics to reduce false-positive assignments. Manual inspection of the dataset performed by us suggested that the identification of at least 510 out of 1108 features reported as unique lipids would require additional experimental evidence. This, in turn, compromises the assignment of collision cross section (CCS) values for 1856 features, potentially misguiding other lipidomics laboratories that may use these CCS data for identifying lipids.Automated lipid species annotation based on fragment ion mass spectra (MS n spectra) faces three major challenges: (i) Isobaric or isomeric lipid species from different classes often yield similar fragments and cannot be unambigiously matched; (ii) the abundance of lipid fragments strongly depends on the experimental conditions 2 which compromises their similarity to reference spectra; (iii) fragmentation of co-isolated precursors often originating from different classes yields highly convoluted spectra. Consequently, further, inspection is indispensable for spectra that were matched to lipid structures by software tools. Rule-based or decision tree-based approaches are more suitable for automated spectral annotation, such as lipid data analyzer (LDA) 2,3 , LipidHunter 4 , LipidXplorer 5 , LipidMatch 6 , and MS-DIAL 7 , to mention only a few common tools. These algorithms scout spectra for fragmentation patterns characteristic to each lipid class according to established fragmentation pathways and peak intensity relationships. Nonetheless, the key for correct unequivocal lipid species annotation lies in two other peculiarities of lipids that do not pertain to the interpretation of MS n spectra: (a) lipids often form more than one adduct ion in electrospray ionization; (b) all
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.